Literature DB >> 10949659

Signal transduction and transcriptional regulation of angiogenesis.

Y Sato1, M Abe, K Tanaka, C Iwasaka, N Oda, S Kanno, M Oikawa, T Nakano, T Igarashi.   

Abstract

When quiescent endothelial cells (ECs) are exposed to angiogenic factor such as VEGF; ECs express proteases to degrade extracellular matrices, migrate, proliferate and form new vessels. However, the molecular mechanism of these events is not fully characterized yet. We are studying the signal transduction and transcriptional regulation of angiogenesis. We investigated the properties of two VEGF receptors, Flt-1 and KDR, by using two newly developed blocking monoclonal antibodies (mAbs), i.e., anti-human Flt-1 mAb and anti-human KDR mAb. VEGF elicited induction of transcription factor Ets-1 in human umbilical vein endothelial cells (HUVECs). This induction was mediated by the KDR/Flt-1 heterodimer and the KDR homodimer. The role of transcription factor Ets-1 in angiogenesis was further clarified. We established both high and low Ets-1 expressing EC lines, and compared angiogenic properties of these cell lines with a parental murine EC line, MSS31. The growth rate was almost identical among three cell lines. It appeared that gene expressions of matrix metalloproteinases (MMP-1, MMP-3, and MMP-9) as well as integrin beta 3 were correlated with the level of Ets-1 expression. As a result, the invasiveness was enhanced in high Ets-1 expressing cells and reduced in low Ets-1 expressing cells compared with parental cells, and high Ets-1 expressing cells made more tube-like structures in type 1 collagen gel. These results indicate that Ets-1 is a principle transcription factor converting ECs to the angiogeneic phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949659     DOI: 10.1007/978-1-4615-4221-6_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

Review 1.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

Review 2.  Pathogenesis of tendinopathies: inflammation or degeneration?

Authors:  Michele Abate; Karin Gravare Silbernagel; Carl Siljeholm; Angelo Di Iorio; Daniele De Amicis; Vincenzo Salini; Suzanne Werner; Roberto Paganelli
Journal:  Arthritis Res Ther       Date:  2009-06-30       Impact factor: 5.156

Review 3.  ETS transcription factors in embryonic vascular development.

Authors:  Michael P Craig; Saulius Sumanas
Journal:  Angiogenesis       Date:  2016-04-28       Impact factor: 9.596

Review 4.  Novel therapeutic strategy for uterine endometrial cancers.

Authors:  Jiro Fujimoto
Journal:  Int J Clin Oncol       Date:  2008-10-23       Impact factor: 3.402

5.  Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects.

Authors:  S Miyazawa-Hoshimoto; K Takahashi; H Bujo; N Hashimoto; Y Saito
Journal:  Diabetologia       Date:  2003-10-08       Impact factor: 10.122

Review 6.  Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries.

Authors:  Kellie K Middleton; Victor Barro; Bart Muller; Satosha Terada; Freddie H Fu
Journal:  Iowa Orthop J       Date:  2012

Review 7.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

8.  Expression of matrix metalloproteinases to induce the expression of genes associated with apoptosis during corpus luteum development in bovine.

Authors:  Sang Hwan Kim; Ji Hye Lee; Jong Taek Yoon
Journal:  PeerJ       Date:  2019-01-30       Impact factor: 2.984

9.  Uncovering a Key Role of ETS1 on Vascular Abnormality in Glioblastoma.

Authors:  Jiefu Tang; Yaling Li; Boxuan Liu; Wei Liang; Sanbao Hu; Meilian Shi; Jie Zeng; Mingzhen Li; Minjiang Huang
Journal:  Pathol Oncol Res       Date:  2021-11-19       Impact factor: 3.201

10.  Overexpression of the Ets-1 transcription factor in human breast cancer.

Authors:  Y Buggy; T M Maguire; G McGreal; E McDermott; A D K Hill; N O'Higgins; M J Duffy
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.